Researchers at the University of Southern California found the drugs, known as 'TSPO ligands', are currently used for certain types of neuroimaging.
"We looked at the effects of TSPO ligand in young adult mice when pathology was at an early stage, and in aged mice when pathology was quite severe," said lead researcher Christian Pike of the USC Davis School of Gerontology.
"TSPO ligand reduced measures of pathology and improved behaviour at both ages," Pike said.
The most surprising finding for Pike and his team was the effect of TSPO ligand in the aged mice.
"Our data suggests the possibility of drugs that can prevent and treat Alzheimer's," Pike said.
"It's just mouse data, but extremely encouraging mouse data. There is a strong possibility that TSPO ligands similar to the ones used in our study could be evaluated for therapeutic efficacy in Alzheimer's patients within the next few years," Pike said.
Next, the team will focus on understanding how TSPO ligands reduce Alzheimer's disease pathology.
The co-authors of the study include USC scientists Anna M Barron, Anusha Jayaraman and Joo-Won Lee; as well as Donatella Caruso and Roberto C Melcangi of the University of Milan and Luis M Garcia-Segura of the Instituto Cajal in Spain.
The study was published in the Journal of Neuroscience.
